Surgalign Holdings (SRGA) Tops Q2 EPS by $1.39

Surgalign Holdings (NASDAQ: SRGA) reported Q2 EPS of ($0.86), $1.39 better than the analyst estimate of ($2.25). Revenue for the quarter came in at $20.6 million versus the consensus estimate of $21.13 million.

For earnings history and earnings-related data on Surgalign Holdings (SRGA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c